{"id":9290,"date":"2017-01-31T20:23:39","date_gmt":"2017-01-31T11:23:39","guid":{"rendered":"http:\/\/cell.brc.riken.jp\/en\/?page_id=9290"},"modified":"2020-12-18T11:25:28","modified_gmt":"2020-12-18T02:25:28","slug":"hps_diseaselist_2","status":"publish","type":"page","link":"http:\/\/cell.brc.riken.jp\/en\/hps\/hps_diseaselist_2","title":{"rendered":"List of diseases ( \uff12 )"},"content":{"rendered":"

*When you want to use some Disease-specific iPS cells, please e-mail to the following address.
\n*In relation to the information that are not described below, please e-mail to the following address.<\/p>\n

Contact us :\u00a0cellips.brc\"\"riken.jp<\/a><\/p>\n

Blue letter cells are available. You obtain the information by clicking the blue letter.
\n*iPS cells created using the Sendai virus vector are now available<\/a><\/p>\n

Update : 2017.02.17
\n<\/a><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Name of diseases<\/th>\nPatient No<\/th>\nHPS<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\nReference<\/th>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
15. Spinal-Bulbar Muscular Atrophy (SBMA)<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Spinal-Bulbar Muscular Atrophy (SBMA)<\/td>\n1<\/td>\nHPS0350<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0479<\/td>\nHPS0480<\/td>\nHPS0481<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
3<\/td>\nHPS0482<\/td>\nHPS0483<\/td>\nHPS0484<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
16. Amyotrophic lateral sclerosis (ALS) <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Amyotrophic lateral sclerosis (ALS)<\/td>\n1<\/td>\nHPS0059<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0247<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0248<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\nHPS0249<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5<\/td>\nHPS0250<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
6<\/td>\nHPS0251<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
7<\/td>\nHPS0252<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
8<\/td>\nHPS0253<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
9<\/td>\nHPS0327<\/a><\/td>\nHPS0290<\/a><\/td>\nHPS0291<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 22855461<\/a><\/td>\n<\/tr>\n
10<\/td>\nHPS0292<\/a><\/td>\nHPS0293<\/a><\/td>\nHPS0294<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 22855461<\/a><\/td>\n<\/tr>\n
11<\/td>\nHPS0419<\/td>\nHPS0420<\/td>\nHPS0421<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
12<\/td>\nHPS0473<\/td>\nHPS0474<\/td>\nHPS0475<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
13<\/td>\nHPS0476<\/td>\nHPS0477<\/td>\nHPS0478<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
14<\/td>\nHPS0485<\/td>\nHPS0486<\/td>\nHPS0487<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
Amyotrophic lateral sclerosis (ALS), familia amyotrophic lateral sclerosis (FALS)<\/td>\n1<\/td>\nHPS0140*<\/a><\/td>\nHPS0141*<\/td>\nHPS0142*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Amyotrophic lateral sclerosis (ALS), bulbar, with UMN (bulbar, with UMN)<\/td>\n1<\/td>\nHPS0146*<\/a><\/td>\nHPS0147*<\/a><\/td>\nHPS0148*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Amyotrophic lateral sclerosis (ALS), classical, with UMN <\/td>\n1<\/td>\nHPS0128*<\/td>\nHPS0129*<\/a><\/td>\nHPS0130*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Amyotrophic lateral sclerosis (ALS), pseudo-polyneuritic, w\/o UMN<\/a><\/td>\n1<\/td>\nHPS0134*<\/a><\/td>\nHPS0135*<\/td>\nHPS0136*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
17. Spinal muscular atrophy <\/a><\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Spinal muscular atrophy, SMA Type I<\/td>\n1<\/td>\nHPS0235*<\/td>\nHPS0236*<\/td>\nHPS0237*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0158<\/td>\nHPS0159<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Spinal muscular atrophy, SMA type III (Kugelberg-Welander disease)<\/td>\n1<\/td>\nHPS0229*<\/td>\nHPS0230*<\/td>\nHPS0231*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0115<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
18. Primary lateral sclerosis (PLS) <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Primary lateral sclerosis (PLS)<\/td>\n1<\/td>\nHPS0414<\/a> <\/td>\nHPS0415<\/td>\nHPS0416<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0417<\/td>\nHPS0418<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
19. Parkinson\u2019s disease (PD) <\/a> <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Parkinson’s disease (PD)<\/td>\n1<\/td>\nHPS0264<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0435<\/td>\nHPS0436<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0491<\/td>\nHPS0492<\/td>\nHPS0493<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a> <\/td>\n<\/tr>\n
4<\/td>\nHPS0509<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5<\/td>\nHPS0510<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Parkinson’s disease (PD), Familial type, PARK2<\/td>\n1<\/td>\nHPS0096<\/td>\nHPS0097<\/a><\/td>\nHPS0098<\/td>\nHPS0099<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\nHPS0304<\/td>\nHPS0305<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
20. Huntington\u2019s disease <\/a> <\/span> <\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Huntington’s disease<\/td>\n1<\/td>\nHPS0263<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
21. Charcot-Marie-Tooth disease <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Charcot-Marie-Tooth disease<\/td>\n1<\/td>\nHPS0426<\/a><\/td>\nHPS0427<\/td>\nHPS0428<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0429<\/a> <\/td>\nHPS0430<\/td>\nHPS0431<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0432<\/td>\nHPS0433<\/td>\nHPS0434<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\nHPS0507<\/a> <\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5<\/td>\nHPS0508<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
22. Congenital myasthenic syndromes <\/a> <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Congenital myasthenic syndromes <\/td>\n1<\/td>\nHPS0982 <\/td>\nHPS0983 <\/td>\nHPS0984 <\/td>\nHPS0985 <\/td>\nHPS0986 <\/td>\nHPS0987 <\/td>\nHPS0988 <\/td>\nHPS0989 <\/td>\nHPS0990 <\/td>\n <\/td>\n<\/tr>\n
2<\/td>\nHPS1066 <\/td>\nHPS1067 <\/td>\nHPS1068 <\/td>\nHPS1069 <\/td>\nHPS1070 <\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
23. Inclusion body myositis <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Inclusion body myositis<\/td>\n1<\/td>\nHPS0181*<\/td>\nHPS0182*<\/td>\nHPS0183*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0351<\/a> <\/td>\n<\/td>\nHPS0352<\/a> <\/td>\n<\/td>\nHPS0353<\/a> \"NEW\"<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
24. Spinocerebellar Degeneration <\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Spinocerebellar Degeneration<\/td>\n1<\/td>\nHPS0422<\/td>\nHPS0423<\/td>\nHPS0424<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0425<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0464<\/td>\nHPS0465<\/td>\nHPS0466<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
4<\/td>\nHPS0467<\/td>\nHPS0468<\/td>\nHPS0469<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
5<\/td>\nHPS1074<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
6<\/td>\nHPS1772 \"NEW\"<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
7<\/td>\nHPS1773 \"NEW\"<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
8<\/td>\nHPS1774 \"NEW\"<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
9<\/td>\nHPS1775 \"NEW\"<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
25. Moyamoya disease <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Moyamoya disease<\/td>\n1<\/td>\nHPS0215*<\/a><\/td>\nHPS0216*<\/td>\nHPS0217*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0241*<\/td>\nHPS0242*<\/td>\nHPS0243*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
26. Congenital myopathy <\/a><\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Congenital fiber type disproportion disease<\/td>\n1<\/td>\nHPS0143*<\/a><\/td>\nHPS0144*<\/td>\nHPS0145*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
27. Muscular dystrophy <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Muscular dystrophy, Duchenne type<\/td>\n1<\/td>\nHPS0163*<\/td>\nHPS0164*<\/a><\/td>\nHPS0165*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0166*<\/td>\nHPS0167*<\/td>\nHPS0168*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\nHPS0169*<\/a><\/td>\nHPS0170*<\/td>\nHPS0171*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\nHPS0312<\/a><\/td>\nHPS0313<\/a> \"NEW\"<\/td>\nHPS0314<\/td>\nHPS0315<\/td>\nHPS0316<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5<\/td>\nHPS0383<\/a> \"NEW\"<\/td>\nHPS0384<\/td>\nHPS0385<\/td>\nHPS0386<\/td>\nHPS0387<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 25434822<\/a><\/td>\n<\/tr>\n
Muscular dystrophy, Duchenne type (manifesting carrier)<\/td>\n1<\/td>\nHPS0317<\/a><\/td>\nHPS0318<\/td>\nHPS0319<\/td>\nHPS0320<\/td>\nHPS0321<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
HPS0322*<\/a><\/td>\nHPS0323*<\/a> \"NEW\"<\/td>\nHPS0324*<\/td>\nHPS0325*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Muscular dystrophy, Becker type<\/td>\n1<\/td>\nHPS0232*<\/td>\nHPS0233*<\/a><\/td>\nHPS0234*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Muscular dystrophy, Limb-girdle type<\/td>\n1<\/td>\nHPS0198*<\/td>\nHPS0199*<\/td>\nHPS0200*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Muscular dystrophy, Miyoshi type <\/td>\n1<\/td>\nHPS0131*<\/td>\nHPS0132*<\/td>\nHPS0133*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Muscular dystrophy, Myotonic Dystrophy<\/td>\n1<\/td>\nHPS0393<\/a> \"NEW\"<\/td>\nHPS0394<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS0395 <\/a> \"NEW\"<\/td>\nHPS0396 <\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>3<\/td>\nHPS0540 <\/a> \"NEW\"<\/td>\nHPS0541<\/td>\nHPS0542<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
28. Periodic paralysis <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Periodic paralysis<\/td>\n1<\/td>\nHPS1062 <\/td>\nHPS1063 <\/td>\nHPS1064 <\/td>\nHPS1065 <\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
29. Frontotemporal dementia <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Frontotemporal dementia<\/td>\n<\/a>1<\/td>\nHPS0470<\/td>\nHPS0471<\/td>\nHPS0472<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a>
\n24399248<\/a><\/td>\n<\/tr>\n
30. Congenital hypomyelinating luekodystrophy <\/a><\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Allan-Herndon syndrome<\/td>\n1<\/td>\nHPS0152*<\/td>\nHPS0153*<\/td>\nHPS0154*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Pelizaeus-Merzbacher disease<\/td>\n1<\/td>\nHPS0066*<\/td>\nHPS0067*<\/td>\nHPS0068*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
31. Xeroderma pigmentosum <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Xeroderma pigmentosum (A)<\/td>\n1<\/td>\nHPS1750 <\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Xeroderma pigmentosum (C)<\/td>\n1<\/td>\nHPS1000 <\/td>\nHPS1001 <\/td>\nHPS1002 <\/td>\nHPS1003 <\/td>\nHPS1004 <\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\nHPS1751 <\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

*When you want to use some Disease-specific iPS cells, please e-mail to the following address. *In relation to the information that are not described below, please e-mail to the following address. Contact us :\u00a0cellips.brcriken.jp Blue letter cells are available. You obtain the information by clicking the blue letter. *iPS cells created using the Sendai virus vector are now available Update : 2017.02.17 Name of diseases Patient No HPS Reference 15. Spinal-Bulbar Muscular Atrophy (SBMA) Spinal-Bulbar Muscular Atrophy (SBMA) 1 HPS0350 2 HPS0479 HPS0480 HPS0481 PMID: 23193063 24399248 3 HPS0482 HPS0483 HPS0484 PMID: 23193063 24399248 16. Amyotrophic lateral sclerosis (ALS) Amyotrophic lateral sclerosis (ALS) 1 HPS0059 2 HPS0247 3 HPS0248 4 HPS0249 5 HPS0250 6 HPS0251 7 HPS0252 8 HPS0253 9 HPS0327 HPS0290 HPS0291 PMID: 22855461 10 HPS0292 HPS0293 HPS0294 PMID: 22855461 11 HPS0419 HPS0420 HPS0421 12 HPS0473 HPS0474 HPS0475 PMID: 23193063 24399248 13 HPS0476 HPS0477 HPS0478 PMID: 23193063 24399248 14 HPS0485 HPS0486 HPS0487 PMID: 23193063 24399248 Amyotrophic lateral sclerosis (ALS), familia amyotrophic lateral sclerosis (FALS) 1 HPS0140* HPS0141* HPS0142* Amyotrophic lateral sclerosis (ALS), bulbar, with UMN (bulbar, with UMN) 1 HPS0146* HPS0147* HPS0148* Amyotrophic lateral sclerosis (ALS), classical, with UMN 1 HPS0128* HPS0129* HPS0130* Amyotrophic lateral sclerosis (ALS), pseudo-polyneuritic, w\/o […]<\/p>\n","protected":false},"author":15,"featured_media":0,"parent":148,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"","_seopress_redirections_param":"","_seopress_redirections_type":0,"_seopress_analysis_target_kw":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-9290","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/9290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/comments?post=9290"}],"version-history":[{"count":7,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/9290\/revisions"}],"predecessor-version":[{"id":10219,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/9290\/revisions\/10219"}],"up":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/148"}],"wp:attachment":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/media?parent=9290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}